Use of tigecycline in elderly patients for Clostridium difficile infection

Geriatrics and Gerontology International

Volumn 15, Issue 2, 2015, Pages 230-231

  Fantin, Francesco ^a   Manica, Angela ^a   Soldani, Fabio ^b   Bissoli, Luisa ^a   Zivelonghi, Alessandra ^a   Zamboni, Mauro ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AZTREONAM; C REACTIVE PROTEIN; CEPHALOSPORIN; CIPROFLOXACIN; CREATININE; DOPAMINE; LEVOFLOXACIN; MEROPENEM; METRONIDAZOLE; PENICILLIN DERIVATIVE; PROCALCITONIN; TIGECYCLINE; VANCOMYCIN; ANTIINFECTIVE AGENT; MINOCYCLINE;

AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIUM IDENTIFICATION; BRONCHOPNEUMONIA; CASE REPORT; CLOSTRIDIUM DIFFICILE INFECTION; CRITICALLY ILL PATIENT; DIARRHEA; DRUG EFFICACY; DYSPNEA; ECHOGRAPHY; FEMUR TROCHANTERIC FRACTURE; FEVER; HOSPITALIZATION; HUMAN; LETTER; LEUKOCYTE COUNT; LEUKOCYTOSIS; MALE; MULTIDRUG RESISTANCE; PEPTOCLOSTRIDIUM DIFFICILE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROTEUS INFECTION; PROTEUS MIRABILIS; PSEUDOMEMBRANOUS COLITIS; RECTOSCOPY; SEPTIC SHOCK; SIGMOIDOSCOPY; THROMBOCYTOPENIA; URINARY TRACT INFECTION; VERY ELDERLY; ANALOGS AND DERIVATIVES; CRITICAL ILLNESS; ENTEROCOLITIS, PSEUDOMEMBRANOUS;

AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CRITICAL ILLNESS; ENTEROCOLITIS, PSEUDOMEMBRANOUS; HUMANS; MALE; MINOCYCLINE;

EID: 84921480318     PISSN: 14441586     EISSN: 14470594     Source Type: Journal    
DOI: 10.1111/ggi.12336     Document Type: Letter

References (10)

1. Bartlett JG. Clinical practice. Antibiotic-associated diarrhea. N Engl J Med 2002; 346: 334-349.
2. Kuijper EJ, Wilcox MH. Decreased effectiveness of metronidazole for the treatment of Clostridium difficile infection? Clin Infect Dis 2008; 47: 63-65.
3. Cohen SH, Gerding DN, Johnson S etal. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010; 31: 431-455.
4. (Olson MM, Shanholtzer CJ, Lee JT Jr etal. Ten years of prospective Clostridium difficile-associated disease surveillance and treatment at the Minneapolis VA Medical Center, 1982-1991. Infect Control Hosp Epidemiol 1994; 15: 371-381.
5. Alfa M, Harding G, Ronald A etal. Diarrhea recurrence in patients with Clostridium difficile-associated diarrhea: role of concurrent antibiotics. J Infect Dis 1999; 10: 287-294.
6. Product information. Tygacil (tigecycline). Philadelphia, PA: Wyeth Pharmaceuticals Inc., July 2010.
7. Hawser SP. Activity of tigecycline against recent European clinical isolates of Clostridium difficile. Int J Antimicrob Agents 2010; 35: 97-98.
8. Herpers BL, Vlaminckx B, Burkhardt O etal. Intravenous tigecycline as adjunctive or alternative therapy for severe refractory Clostridium difficile infection. Clin Infect Dis 2009; 48 (12): 1732-1735.
9. Larson KC, Belliveau PP, Spooner LM. Tigecycline for the Treatment of Severe Clostridium difficile Infection. Ann Pharmacother 2011; 45: 1005-1010.
10. Venugopal AA, Johnson S. Current state of Clostridium difficile treatment options. Clin Infect Dis 2012; 55 (Suppl 2): S71-S76.